Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
low-dose follicle-stimulating hormone
- Development stage
- Preclinical
- Lead developer
- Guna
- Modality
- Peptides
- Administration
- Oral
01
Overview
low-dose follicle-stimulating hormone (Guna-FSH) is an ultra-low-dose homeopathic formulation of follicle-stimulating hormone (FSH) developed by Guna S.p.a. for the treatment of reproductive dysfunctions, specifically polycystic ovary syndrome (PCOS). Utilizing the principles of Physiological Regulating Medicine (PRM), the formulation delivers FSH at concentrations typically in the picogram or nanogram range (e.g., 4CH dilution). The mechanism of action involves the modulation of the follicle-stimulating hormone receptor (FSHR) to restore the physiological balance between luteinizing hormone (LH) and FSH, thereby promoting follicular maturation and attenuating hyperandrogenism-related reproductive dysfunction. It is administered orally as drops and is currently in the preclinical stage of development for PCOS.
- Brand names
- Guna-FSH
- Other names
- homeopathic follicle-stimulating hormoneultra-low-dose follicle-stimulating hormoneGuna-FSH
02
Targets
FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on low-dose follicle-stimulating hormone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on low-dose follicle-stimulating hormone.